Peter Harwin is a managing member at Fairmount Funds Management, a healthcare investment firm he co-founded in 2016. Prior to Fairmount, he was a member of the investment team at Boxer Capital, an investment fund that was part of the Tavistock Group, based in San Diego. Mr. Harwin also serves as chairman of the board of directors of Cogent Biosciences (Nasdaq: COGT), and is a member of the board of directors of Apogee Therapeutics (Nasdaq: APGE), Viridian Therapeutics (Nasdaq: VRDN) and Spyre Therapeutics (Nasdaq: SYRE). He earned a BBA from Emory University.